Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III parallel-group comparison of HP-3000 patch versus oral ropinirole in Parkinson's disease patients using L-DOPA
jRCT2080222818Phase 3
- Sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Start
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ropinirole in Parkinson's disease (PD) (2 arms), sponsored by Hisamitsu Pharmaceutical Co., Inc.
02
Drugs
ropinirole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2080222818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222818.